Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

India's Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose

Published 2021-04-21, 03:43 a/m
Updated 2021-04-21, 03:48 a/m
© Reuters. FILE PHOTO: Officials unload boxes containing vials of COVISHIELD vaccine outside a vaccination storage centre in Ahmedabad

© Reuters. FILE PHOTO: Officials unload boxes containing vials of COVISHIELD vaccine outside a vaccination storage centre in Ahmedabad

NEW DELHI (Reuters) - The Serum Institute of India said on Wednesday it would sell the AstraZeneca (NASDAQ:AZN) vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95).

"Furthermore, owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity," it said in a statement. "We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems."

© Reuters. FILE PHOTO: Officials unload boxes containing vials of COVISHIELD vaccine outside a vaccination storage centre in Ahmedabad

($1 = 75.4620 Indian rupees)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.